
Results
4
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
4 companies
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€92.40
7D
1.5%
1Y
20.8%
Oryzon Genomics
Market Cap: €217.8m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.81
7D
0.7%
1Y
1.1%
Ercros
Market Cap: €311.8m
Manufactures and sells chemical and pharmaceutical products in Spain and internationally.
ECR
€3.41
7D
-0.1%
1Y
19.0%
Adolfo Domínguez
Market Cap: €47.5m
Engages in the design, manufacture, acquisition, sale, marketing, retail, import, and export of ready-made garments, footwear, handbags and accessories, household linen, furniture, and decorative objects.
ADZ
€5.15
7D
3.8%
1Y
11.5%